A single syllable buried on page fourteen of a patent specification once determined whether a pharmaceutical company kept exclusive rights to a product line worth hundreds of millions of dollars. Nobody in the boardroom noticed it. Nobody flagged it during filing. It...
Three hundred and fifty billion dollars is currently crossing the Pacific — and every dollar of it travels on paper written in two languages. Under the trade agreement finalized between Seoul and Washington in late 2025, Korea pledged $350 billion in investments into...
On the first of May this year, a quiet regulatory deadline redrew the standard for an entire profession. From that date, hundreds of additional companies listed on Korea's benchmark stock index — every firm with assets of two trillion won or more, 265 companies by the...